Deutsche Bank set a €52.00 ($60.47) target price on Brenntag (FRA:BNR) in a research note published on Thursday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
BNR has been the topic of a number of other reports. UBS Group cut their target price on shares of Wells Fargo & Co from $53.00 to $51.00 and set a buy rating on the stock in a research report on Wednesday, July 17th. Warburg Research set a €1.45 ($1.69) target price on shares of Heidelberger Druckmaschinen and gave the company a neutral rating in a research report on Thursday. Goldman Sachs Group set a €100.00 ($116.28) target price on shares of Henkel AG & Co KGaA and gave the company a buy rating in a research report on Wednesday, July 17th. Jefferies Financial Group cut their target price on shares of Seres Therapeutics from $6.00 to $4.00 and set a hold rating on the stock in a research report on Monday, July 1st. Finally, JPMorgan Chase & Co. set a €50.00 ($58.14) target price on shares of Brenntag and gave the company a buy rating in a research report on Tuesday, July 16th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company currently has an average rating of Buy and an average price target of €52.77 ($61.36).
Shares of FRA:BNR opened at €43.60 ($50.70) on Thursday. Brenntag has a 12 month low of €43.06 ($50.07) and a 12 month high of €56.25 ($65.41). The stock’s 50-day moving average is €43.04.
Brenntag Company Profile
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Read More: Why is insider trading harmful?
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.